Medidata has announced its expanded partnership with Horizon Therapeutics plc. Starting with one technology solution, Medidata will provide a suite of solutions for Horizon’s clinical research needs in multiple therapeutic areas including ophthalmology, rheumatology, and nephrology.
Horizon will access a broad range of clinical trial solutions using the Medidata Rave Clinical Cloud. Horizon will use Medidata’s Intelligent Trials product, which brings artificial intelligence, partnered with advanced analytics, to bring cross-industry real-time performance metrics, predictive models, and forecasting capabilities for trial planning and execution.
For more information, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.